{"url":"https://lda.senate.gov/api/v1/filings/e8582bbc-bd23-4919-a8eb-ecc86def5cae/","filing_uuid":"e8582bbc-bd23-4919-a8eb-ecc86def5cae","filing_type":"1T","filing_type_display":"1st Quarter - Termination","filing_year":2019,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/e8582bbc-bd23-4919-a8eb-ecc86def5cae/print/","filing_document_content_type":"text/html","income":null,"expenses":"80000.00","expenses_method":"a","expenses_method_display":"Method A - Reporting amounts using LDA definitions only","posted_by_name":"Shetera Patterson","dt_posted":"2019-04-22T19:15:00.517000-04:00","termination_date":"2019-03-29","registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2225 Colorado Avenue","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Santa Monica","registrant_state":"CA","registrant_zip":"90404","registrant":{"id":401104745,"url":"https://lda.senate.gov/api/v1/registrants/401104745/","house_registrant_id":null,"name":"KITE PHARMA, INC.","description":"Pharmaceutical Manufacturer","address_1":"2225 Colorado Avenue","address_2":null,"address_3":null,"address_4":null,"city":"Santa Monica","state":"CA","state_display":"California","zip":"90404","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SHETERA PATTERSON","contact_telephone":"+1 213-212-8576","dt_updated":"2022-04-06T16:06:53.647856-04:00"},"client":{"id":202607,"url":"https://lda.senate.gov/api/v1/clients/202607/","client_id":12,"name":"KITE PHARMA, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"CA","state_display":"California","country":"US","country_display":"United States of America","ppb_state":"CA","ppb_state_display":"California","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-07-17"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to CAR T; policy issues relating to Medicare inpatient and outpatient reimbursement, including the New Technology Add-on Payment program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67715,"prefix":null,"prefix_display":null,"first_name":"ANNA","nickname":null,"middle_name":null,"last_name":"GRIFFIN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}